Paul Kellam
St Marys Campus, Norfolk Place
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 163 publications
Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung disease.
Journal: NPJ vaccines
Published: April 24, 2025
A Transgenic Mouse With a Humanized B-Cell Repertoire Mounts an Antibody Response to Influenza Infection and Vaccination.
Journal: The Journal of infectious diseases
Published: June 21, 2024
Exploiting human immune repertoire transgenic mice for protective monoclonal antibodies against antimicrobial resistant Acinetobacter baumannii.
Journal: Nature communications
Published: October 01, 2023
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein.
Journal: Cell reports
Published: July 23, 2023
Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.
Journal: NPJ vaccines
Published: June 05, 2023
Deep mutagenesis scanning using whole trimeric SARS-CoV-2 spike highlights the importance of NTD-RBD interactions in determining spike phenotype.
Journal: PLoS pathogens
Published: February 13, 2023
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.
Journal: NPJ vaccines
Published: December 25, 2022
Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii.
Journal: The Journal of infection
Published: November 15, 2022
Last Updated: 09/26/2026